GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (XSWX:COPN) » Definitions » Cyclically Adjusted PB Ratio

Cosmo Pharmaceuticals NV (XSWX:COPN) Cyclically Adjusted PB Ratio : 2.25 (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Cosmo Pharmaceuticals NV Cyclically Adjusted PB Ratio?

As of today (2024-04-28), Cosmo Pharmaceuticals NV's current share price is CHF71.60. Cosmo Pharmaceuticals NV's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec22 was CHF31.89. Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio for today is 2.25.

The historical rank and industry rank for Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio or its related term are showing as below:

XSWX:COPN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.06   Med: 4.9   Max: 32.88
Current: 2.25

During the past 13 years, Cosmo Pharmaceuticals NV's highest Cyclically Adjusted PB Ratio was 32.88. The lowest was 1.06. And the median was 4.90.

XSWX:COPN's Cyclically Adjusted PB Ratio is ranked worse than
58.58% of 647 companies
in the Drug Manufacturers industry
Industry Median: 1.75 vs XSWX:COPN: 2.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cosmo Pharmaceuticals NV's adjusted book value per share data of for the fiscal year that ended in Dec22 was CHF27.732. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is CHF31.89 for the trailing ten years ended in Dec22.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cosmo Pharmaceuticals NV Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV Cyclically Adjusted PB Ratio Chart

Cosmo Pharmaceuticals NV Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.52 3.50 3.51 2.34 1.92

Cosmo Pharmaceuticals NV Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.34 - 1.92 -

Competitive Comparison of Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio falls into.



Cosmo Pharmaceuticals NV Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=71.60/31.89
=2.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Pharmaceuticals NV's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec22 is calculated as:

For example, Cosmo Pharmaceuticals NV's adjusted Book Value per Share data for the fiscal year that ended in Dec22 was:

Adj_Book=Book Value per Share/CPI of Dec22 (Change)*Current CPI (Dec22)
=27.732/115.4249*115.4249
=27.732

Current CPI (Dec22) = 115.4249.

Cosmo Pharmaceuticals NV Annual Data

Book Value per Share CPI Adj_Book
201312 18.135 99.875 20.958
201412 12.987 99.576 15.054
201512 31.023 99.676 35.925
201612 31.683 99.676 36.689
201712 36.517 100.075 42.118
201812 33.754 100.773 38.662
201912 29.614 102.068 33.489
202012 29.962 101.072 34.217
202112 31.473 106.653 34.061
202212 27.732 115.425 27.732

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cosmo Pharmaceuticals NV  (XSWX:COPN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cosmo Pharmaceuticals NV Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmo Pharmaceuticals NV (XSWX:COPN) Business Description

Traded in Other Exchanges
Address
Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2
Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.

Cosmo Pharmaceuticals NV (XSWX:COPN) Headlines

No Headlines